Unilever explores bid for supplements maker Thorne in deal valued at up to $4B
Seeking Alpha ·
Unilever ( UL ) is exploring a bid for U.S. supplements maker Thorne, which has been put up for sale by private equity owner L Catterton ( LCLA ) in a deal that could value the business at as much as $4
DYAX Investor Sentiment
Bullish (Long) 31% · Bearish (Short) 69%
400 participants
Related News
- Amazon's AWS raises prices for renting GPU capacity in several regions
- Anthropic checks show coding improvements via Fable: Wells Fargo
- Semiconductor stocks retreat over worries about memory costs
- KULR extends pause on ATM equity offering through September 2026
- Polymarket's annualized revenue reaches over $1B in light of FIFA World Cup - report
- Travel and e-commerce companies lead consumer discretionary growth rankings